# Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia

> **NCT00618371** · NA · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 10 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Raltegravir (MK-0518)

## Key facts

- **NCT ID:** NCT00618371
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618371, "Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00618371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*